Search for: "Teva Pharmaceuticals" Results 1061 - 1080 of 1,430
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jun 2010, 10:37 pm by Carey, Danis & Lowe
It targets the companies Pliva Pharmaceuticals, Barr Laboratories, Teva Pharmaceuticals and Watson Pharmaceuticals — all are generic manufacturers of Reglan. [read post]
22 Jun 2010, 11:18 pm by Law Office of Stephen Gorey
This would not harm anyone EXCEPT that if the same vial is now used for a second patient, that second patient becomes infected even if the needle has been changed because the bottle, not the needle, is now growing the infection inside the liquid.This has led to terrible injuries due to Hepatitis C, B and HIV being transmitted in colonoscopy clinics and other offices administering the tests with Propofol used to induce a twilight state of consciousness.Recently a jury found this infection process to… [read post]
17 Jun 2010, 3:13 am by Ted Frank
Fallout from the ludicrous $356 million Teva Pharmaceuticals verdict (and earlier): Teva is announcing that it "will stop production of its sedative propofol, which many worry will intensify an already existing shortage of one of the most widely used anesthetics in the United States. [read post]
16 Jun 2010, 10:06 pm by Walter Olson
Following a Nevada jury’s highly controversial $500 million verdict over allegedly inadequate warnings against multiple patient use, as well as bad publicity over possible abuse by music legend Michael Jackson, “Israel-based Teva Pharmaceutical Industries recently announced it will stop production of its sedative propofol, which many worry will intensify an already existing shortage of one of the most widely used anesthetics in the United States. [read post]
14 Jun 2010, 4:30 am by Laura Simons
In the wake of two headline-grabbing hits to its image and to its wallet, Israel-based Teva Pharmaceutical Industries recently announced it will stop production of its sedative propofol, which many worry will intensify an already existing shortage of one of the most widely used anesthetics in the United States.We here at Abnormal Use previously reported on one of these two potential catalysts to the halt in production here, where we evaluated the Nevada jury's… [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva,… [read post]
1 Jun 2010, 8:16 am by law shucks
He was the lead trial lawyer for Forest Laboratories Inc. in an effort to block Teva Pharmaceutical Industries Ltd. from selling a generic version of the antidepressant Lexapro. [read post]
27 May 2010, 6:51 am by Carey, Danis & Lowe
Within the last two months, I've written about three other companies whose manufacturing practices have been under FDA's scrutiny, including McNeil Pharmaceuticals, Teva Pharmaceuticals and KV Pharmaceutical. [read post]
24 May 2010, 12:54 pm by FDABlog HPM
”)  In the latest lawsuit, MDCO and the PTO have filed cross-motions for summary judgment (here and here) and generic applicants Teva and APP Pharmaceuticals have filed amicus briefs (here and here). [read post]
24 May 2010, 4:25 am by Ted Frank
Second, as the Abnormal Use blog documents, much of the jury's anger against the innocent bystander reflected a Cartmanesque petulance that the defendants failed to kowtow to the jury enough: Teva Pharmaceuticals didn't send an executive to monitor the trial, and Baxter Healthcare's executive offended the jury by "stammering" on the stand. [read post]
20 May 2010, 8:31 am
But again today, May 20, 2010 the firm has upgraded the stock from Hold to Buy.According to Benzinga’s Monica Gerson who writes that Standpoint analyst Ronnie Moas had also upgraded shares of Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA), Dell Inc (NASDAQ: DELL), HP (NYSE: HPQ) and Xerox Corporation (NYSE: XRX), simultaneously, from “hold” to “buy. [read post]